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Abstract
Background: The aim of this study is to investigate the physicochemical and structural properties of Medifoam®Silver
and to compare with other commercially available silver-containing polyurethane (PU) foam dressing in vitro.
Methods: Surface and cross-section of four polyurethane foam dressings were assessed with field-emission scanning
electron microscope. Thickness, density, tensile strength, elongation, absorption rate, absorption/retention capacity and
water-vapor transmission (WVT) were measured to compare physical properties of various dressing materials.
Results: Among four tested dressings, Medifoam®Silver has relatively uniform and smallest pore size in both surface
and cross-section. In comparison of absorption properties with other dressing materials, Medifoam®Silver has rapid
absorption rate, good absorption/retention capacity and good WVT value.
Conclusions: The data further suggests that Medifoam®Silver is a promising candidate for wound healing management.
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Background
The aim of wound dressings is to promote tissue regen-
eration and ultimately to speed up wound healing, to re-
duce infections and minimize pain [1]. The benefits of
an optimal moist environment at the wound interface in
terms of facilitating wound closure and spending up the
healing process are well described [2]. Wet wound
dressings may provide optimal conditions not only for
proliferation of healthy cells but also for bacterial growth
[3]. Furthermore, the absorption/retention performance
of wet wound dressing material drives absorption of
exudate and plays an important role in moisturized
wound environment. Subsequently, the balanced moist
environment at the wound interface is known to facili-
tate closure and fast healing process [4].
Wound infection commonly occurs from inappropriate
cleansing, debridement, dressing techniques as well as
exposure to contaminated sources, and represents a major
barrier to wound healing [5]. Due to potential bacterial
resistance, topical use of antibiotics for non-infected
wound is discouraged but still it is very commonly used
[6]. Topical silver creams and solutions have been exten-
sively used for wound healing since they offer a broad
spectrum of antimicrobial activity, less development of
resistance, fewer adverse reactions, and a low risk of
systemic toxicity [7, 8]. However, these agents normally
require frequent application, care-intensive applica-
tion/removal, and cause painful reaction in patients
[8–10]. Since silver-compounds such as silver nitrate
and silver sulfadiazine is known to have antibacterial
activity, it has been widely used in wound healing
treatment as a silver-containing dressings or topical
creams [11, 12]. Many reports describe that silver-based
dressings are helpful to overcome bacterial infections, to
promote environment for granulation/re-epithelialization
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in wound area, reduce adverse effects and to facilitate
wound healing [2, 3, 10, 11].
Modern silver dressings should maintain moisture
balance by absorbing excess exudate and preventing the
wound drying out, while conferring antibacterial protec-
tion in wounds at risk of infection [2, 4]. The physical
property of foam dressing should be maintained when it
is coated with silver. In our previous report, we showed
that our wound dressing, Medifoam® N, has excellent
physicochemical properties when compared with other
dressing materials [13]. Furthermore, we also showed
that appropriate physicochemical properties of wound
dressing material such as porous structure, thickness/
density, tensile strength and moisture-vapor transmis-
sion rate contributed to improve performance of wound
dressing material. Since silver-compound has been dem-
onstrated in the protection of bacterial contamination
and then facilitation of re-epithelialization in the wound
area, we developed silver-containing wound dressing
(Medifoam®Silver), it may contribute to improve efficacy
of wound dressing material against contamination
circumstances and to facilitate wound healing. Further-
more, excellent physicochemical proeprties of our wound
dressing material may also contribute to improve effi-
ciency of wound healing. For example, Yunoki et al., re-
ported that physicochemical properties of wound dressing
such as release of silver was contributed to antibacterial
activity of wound dressing material [14]. Furthermore,
other researchers also investigated physicochemical prop-
erties and antimicrobial efficiency [15, 16].
This study was conducted to compare physicochemical
properties including pore size, absorption and retention
capacity, and in vitro antibacterial activities of Medi-
foam®Silver to those of other marekted silver-dressings.
Methods
Materials
Silver impregnated dressings such as Medifoam®Silver
(Genewel Co., Ltd, South Korea), AAG (Allevyn® AG
(Smith & Nephew Co. TX, USA)). MAG (Mepilex® AG
(Mölnlycke Health Care Co. Sweden)) and PS (Polymem®
Silver (Ferris Manufacturing Co. Illinois, USA)) were
obtained or purchased from each respective company.
Phosphate-buffered saline (PBS, pH 7.4, 0.01 M, with
pigment (SCU656, 0.1 %, DaeBo Co. ltd, Gyeonggi-do,
Korea) was purchased from Gibco (NY, USA). All organic
solvents were used as HPLC grade without further
purification.
Thickness and density measurements
Thickness was measured using MDH micrometer high
accuracy sub-micron digimatic micrometer (CD-15CPX,
Mitutoyo Co. Ltd., Kawasaki, Japan) repeatedly at least
10 times with different samples. The value of thickness
was described in mm as mean ± standard deviation.
Density was calculated from measurement of (weight,
width, length and thickness) of the foam dressing mate-






width  length  thickness
Density measurement was also repeated at least 10
times with different samples (Mean ± standard deviation).
Morphology assessment
To assess morphology of foam dressing, field-emission
scanning electron microscope (FE-SEM, S-4800, Hitachi,
Tokyo, Japan) was employed. Each foam dressing was
cut into uniform size and then coated by platinum
coater. The prepared specimens were assessed at 25 kV.
In the morphology analysis, the pore size and pore size
uniformity of each dressing were measured and com-
pared. Pore size was measured directly from the photo
with a ruler. At least, more than three photos were taken
from different positions and used to analyze pore size
measurement.
Tensile strength and elongation
Material test machine (3343Q9831, Instron Co., MA,
USA) was used for measuring tensile strength. Foam
dressings were carefully clipped out of Dog-bone
(6 mm × 105 mm) using a wood-molded blade with
maintenance of the surface of foam dressing unscathed.
Clipped foam dressing was installed into the test
machine symmetrically across the cross-section of the
grip of the instrument. Foam dressings were pulled out
(speed: 300 mm/min) at a snap and the value was
calculated in the following equation: [Tensile Strength
(kgf/cm2) =MAX Failure Strength (kgf)/Cross-section of
Specimen (mm2)]. Elongation was calculated in the
following equation:




D1: Initial Inter-clip Distance. D2: Inter-clip Distance
at Snap.
Absorption rate
Absorption rate was measured as follows: After dressing
materials were placed onto flat surfaces, phosphate-
buffered saline (PBS, pH 7.4, 0.01 M) solution was pipetted
onto the wound contact layer at the height of 1.0 ± 0.5 cm.
The absorption rate of PBS was measured using stopwatch,
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repeatedly, minimum five times. The values were expressed
as mean ± standard deviation.
Absorption and retention capacity
Absorption and retention capacity was carried out in
accordance with BS EN 13726–1:20022. Five samples of
foam dressings measuring 5 × 5 cm were prepared to
measure absorption capacity. The baseline weight (W1)
and thickness (T) of each sample was recorded. Distilled
water (37.0 ± 1 °C) equal to 40 times of the weight of the
sample was added to each experimental sample.
Temperature of distilled water was constantly controlled
with Pyrostat (OF-21E, Jeio Tech, Daejeon, Korea) at
37 °C for 30 min. After 30 min, dressings were sus-
pended and then weighed for 30 s (W2). The absorption






Initial area of dressing cm2ð Þ
 
The absorption and retention capacity was measured.
Initial weight (A) and thickness (B) of dressings were
measured to similar with absorption study. Once absorp-
tion rate was measured, each sample was pressed by a
5 kg weight (111209, Jongro industrial Co., Ltd., Seoul,
Korea) for 20 s and then weighed again (W3). Then, the
retention weight (D) was calculated with following
formula: Retention capacity (g/cm2) = W3 –W1/ini-
tial specimen area (cm2). The mean absorption and re-
tention of the samples of each product were calculated.
Water-vapor transmission (WVT) measurement
The WVT value of dressing materials was measured as
follows: Aluminum cups with diameter of 62 mm and
absorptive area of 0.0028 m2 were preheated in a dry oven
(100 °C) and placed with CaCl2 (20 g). Each dressing was
tied onto the top of the aluminum cup. Ten glass bottles
were used for each dressing. The specimen was set to face
CaCl2 in the aluminum cup and the dead center of the
cup to create a concentric ring. To seal the edges, pre-
heated paraffin solution in a dry oven (100 °C) was poured
along the edge of the absorptive cup (beaker) and then
paraffin debris was removed thereafter. The joint
aluminum cups containing CaCl2 and covering dressing
was weighed for baseline (W1) and 24 h after it was placed
into the thermo-hygrostat (37 °C, 75 % humidity) (W2).









W1 : initial weight of the sample before put into the
thermo-hygrostat.
W2 : weight of the sample in thermo-hygrostat after 24 h.
B : absorptive area (0.0028 m2).
Antibacterial activity
The antimicrobial activity of the foam dressings was
compared against Staphylococcus aureus and Pseudo-
monas aeruginosa obtained from the American Type
Culture Collection (ATCC, Manassas, VA, USA); ATCC
6538 and ATCC 10145, respectively. To evaluate anti-
microbial activity, the dynamic shake flask test was used.
Briefly, 50 ml of culture inoculum containing approxi-
mately 1×106 CFU/ml were added to a sterile 250 ml
screw-cap Erlenmeyer flask (Triforestlabware, CA, USA).
Bacterial concentration of solution was determined at the
“0” time by performing serial dilutions and standard plate
count techniques from the “inoculum only” sample flask.
Each dressing (1 cm × 1 cm) was placed in the individual
flask and incubated under dynamic conditions at 32 °C.
Following incubation, at different time intervals (1 min,
5 min, 10 min, 20 min, 30 min, and 1 h), the dressings
were removed and the resulting suspensions were
incubated at 35 °C for 24 h in Petri dishes (BD(Becton
Dickinson), CA, USA). The numbers of colonies (CFU/ml)
for the dressing-containing flask (A) and for the “inoculum
only” flask (B) were counted. The reduction of microorgan-
isms (%) for each dressing was calculated using the follow-
ing formula;
Log10 reduction LRð Þ ¼ log10 Bð Þ ‐ log10 Að Þ
Percent reduction %ð Þ ¼ 100  1 ‐ 10‐LR 
Statistical analysis
All experimental data were expressed as mean ± standard
deviation (S.D.). Statistical alaysis was evaluated by
Student’s t test using Sigmaplot program (Sigmaplot ver-
sion 11.2, Systat software, Inc., CA, USA) and p value <
0.05 was considered as statistically significant.
Results
Physico-chemical properties of foam dressings
In this study, we compared the physical and structural
properties of Medifoam®Silver, with several other com-
mercially available dressings. Medifoam®Silver features
an absorptive SSD-containing polyurethane foam layer
between a semi-permeable absorptive polyurethane film
wound contact layer and an outer layer of breathable
film. Since properties of the dressing such as thickness,
density, and morphology have primary importance in
wound healing potential, those were evaluated as shown
in Figs. 1, 2 and Table 1. As shown in Fig. 1(a), thickness
of Medifoam®silver was 5.05 mm. Allevyn® Ag and
Polymem®silver has largest and smallest thickness,
respectively. Figure 1(b) shows density of foam dressings.
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Medifoam®silver and Polymem®silver showed higher
density than others.
The morphology of foam dressings in surface and
cross-section were assessed with FE-SEM as shown in
Fig. 2. The morphology of surface as a wound contact
layer was shown in Fig. 2A. Surface of Medifoam® Silver
showed uniform and small pore size as shown in
Fig. 2A(a). In the surface area, Polymem®silver had a lar-
gest pore-size, followed by Mepilex®Ag, then, by Allevyn®
Ag in descending order. The pore size of the cross
sections was the same in order, largest in Polymem®silver,
followed by Mepilex®Ag and Allevyn® Ag. The size of pore
in foam dressing is summarized in Table 1.
Figure 3 showed tensile strength and elongation of
foam dressings. As shown in Fig. 3(a), Mepilex®Ag showed
good tensile strength and elongation. Medifoam®Ag has
low tensile strength but its elongation was optimal.
Allevyn®Ag has good tensile strength but its elongation
value was low.
Absorption and retention properties of foam dressings
Absorption properties of foam dressings were shown in
Fig. 4. As shown in Fig. 4(a), absorption rate of
Medifoam®Silver and Polymem®silver was faster than other
dressings. Mepilex®Ag required the longest absorption
period. Furthermore, Medifoam®Silver showed high
absorption/retention capacity as shown in Fig. 4(b),
i.e. the average absorption and retention capacity of
Medifoam®Silver was 1.25 and 0.43 g/cm2, respectively.
Antibacterial activity of silver-containing dressings
As in Fig. 5(a), antibacterial activity against Staphylococcus
aureus subst. and Psudomonas aeruginosa was clearly
recognized in all silver dressing-treated samples, while
gauze-treated samples showed full of microbial growth.
Numerically, all silver dressing-treated samples showed
99.9 % bacterial inhibition against Staphylococcus aureus
subst. and Psudomonas aeruginosa in comparison to
gauze-treated sampled (Fig. 5(b) and (c)). These re-
sults indicated that Medifoam®Silver, has excellence
bacteriocidal effect against both Pseudomonas aerugi-
nosa and Staphylococcus aureus subst. Silver dressing
including a silver sulfadiazine had good antibacterial
activity in a diabetic rat model with a MRSA infection
[11]. Therefore, Medifoam®Silver, which is also wound
dressing containing silver sulfadiazine, can be assumed to
be effective in inhibition of bacterial growth in wound
healing. The data suggests Medifoam®Silver as a promising
candidate for wound care.
Fig. 1 Thickness (a), density (b) of foam dressing. *,** : p < 0.001
Fig. 2 Morphological assessment of foam dressing by FE-SEM. A Surface (wound contact layer): (a) Medifoam silver, (b) Allevyn Ag, (c) Mepilex
Ag, and (d) Polymem silver. B Cross-section: (e) Medifoam silver, (f) Allevyn Ag, (g) Mepilex Ag, and (h) Polymem silver
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Discussion
Excessive exudate in wound healing management
induces delayed healing process, maceration of peri-
wound skin and embarrassing leakage for the patient [2].
The pore size and pore morphology of wound dressing
material may contribute the potential of wound dressing
in the wound healing process. We previously reported
that small pore size. Pore structure and its uniformity of
Medifoam® N is related to moisture-vapor transmission
rate and fluid absorption/retention capacity, and these
excellent physicochemical properties must be contributed
to improve wound healing process [13]. The smaller pore
size and uniformity of the surface and cross-section
preferentially affect the microenvironment of wound area
with its property of capillary absorption, retention
capacity, WVT for exudate. Chitrattha and Phaechamud
reported that porosity and pore size significantly influ-
enced on WVT, drug release rate and oxygen transmission
rate, and these properties were deeply related to antibac-
terial activity [17].
In addition, the pore size considered to play an essential
role in minimizing fibroblast/keratin ingrowth into the
device and reducing secondary damage upon dressing
change [18]. Moreover, dressing material having wet and
incubator-like microenvironment can provide clear
advantages such as prevention of dehydration, control of
bacterial penetration, and bullae formation [19]. Med-
ifoam®Silver features an absorptive SSD-containing poly-
urethane foam layer between a semi-permeable absorptive
polyurethane film wound contact layer and an outer layer
of breathable film. These physical properties in thickness,
density as well as pore strucuture and size were designed
to optimize absorption and retention properties in clinical
wound healing practice. Furthermore, the absorption and
retention rates for silver dressings have been limitedly
reported. One study investigated the water absorption
rates of four dressings (carbon fiber, hydrogel, silver
nanoparticle, and Vaseline gauze) used in patients
with partial-thickness burns [20]. The absorption rates
were highest with the carbon fiber dressing, with the
rates of the silver nanoparticle dressing being next
highest. Compared with wounds without a dressing,
evaporation from dressed wounds decreases [20]. In
another study comparing various wound dressings, a
nanoparticle silver dressing showed good absorptive
properties, absorbing up to 30 % of its weight after
72 h in a high-humidity environment [21].
The current study showed the good absorption and
retention capacity of Medifoam®Silver. Advanced wound
dressing material having ideal physical/structural proper-
ties can effectively absorb excess exudate from wound
interface, prevent dryness of wound by maintaining bal-
anced moisture condition, and provide barrier function
against bacterial infections [2, 4]. Therefore, Medifoam®-
Silver would have optimal performance in absorption
and retention of biological solutions and secretion from
actual wounds. Furthermore, Medifoam®Silver has
certain tensile strength and elongation properties as
shown in Fig. 3. Those were considered to be an import-
ant factor for maintaining physicochemical properties,
controlling drug release/WVT/MVTR and antibacterial
activity [22, 23]. The absorption and retention capacity
of Medifoam®Silver was good in comparison to those of
several commercially available silver dressings. Given the
detrimental effects of excessive moisture loss and potential
for infection in wounds, highly absorptive and moisture
retentive dressings such as BETAplast, are a welcomed
addition to wound management armamentarium.
Table 1 Pore size of foam dressings
Pore size (μm)
Surface Cross-section
Size distribution Average Size distribution Average
Medifoam®silver 25–75 69.2 100–350 274.8
Allevyn®Ag 70–90 78.6 370–500 422.4
Mepilex®Ag 100–250 150.8 350–500 441.6
Polymem®silver 130–250 195 900–1500 1236
Fig. 3 Tensile strength (a), and elongation (b) of foam dressings. *,** : p < 0.05
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When physicochemical and structural properties of
Medifoam®Silver were examined, it demonstrated suitable
thickness, density, tensile strength and elongation. The mor-
phologic study of Medifoam®Silver has shown the smallest
pore size and the best uniformity of pore among tested
dressings in both contact layer and cross-section. It also
exhibited fast absorption rate, good absorption/reten-
tion capacity and good WVT value. In addition, antibac-
terial activity of Medifoam®Silver was equivalent to
other commercially available silver foam dressings. With
its optimal physicochemical and antibacterial activity,
Medifoam®Silver is expected to contribute to improved
wound healing process.
Conclusion
Our in vitro studies give a better understanding of the results
achieved with Medifoam®Silver in an uncontrolled clinical
study in burn wounds [24]. Randomized clinical trials of silver
wound dressings are difficult to conduct because of the multi-
tude of potential comparators, practices and the many types
of wound to treat. Nevertheless, clinical case studies or even
selected clinical trials may confirm insight from this study.
Fig. 4 Comparison of absorption rate (a), absorption/retention capacity (b), and WVT value (c) of foam dressings. *: p < 0.001; **,***,**** : p < 0.01
Fig. 5 (a) comparison of antibacterial activity in vitro of foam dressings. Antibacterial effect of silver dressing against Pseudomonas aeruginosa and
Staphylococcus aureus subst. (ATCC6538). b and c were reduction ratio of Pseudomonas aeruginosa and Staphylococcus aureus subst., respectively.
Logarithmic reduction ratio was calculated as detailed in the method section (Antibacterial activity). *, ** : p < 0.05
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